Troy Groetken is a Shareholder, Board Member, and Executive Committee member with McAndrews. He has approximately 30 years of legal experience in the intellectual property field and more than 30 years of technical experience in the pharmaceutical, biotechnological, and chemical fields. He is recognized by IAM’s Patent 1000: The World’s Leading Patent Professionals, Strategy 300, and Strategy 300: Global Leaders. He is also recognized as an IP Star by Managing IP and has been listed as one of the Best Lawyers in America since 2012.

As a registered U.S. patent practitioner, Troy regularly counsels and is known globally as the “go-to” intellectual property attorney for Fortune 100 and 500 clients regarding complex intellectual property matters involving strategic global patent portfolio development, implementation, and enforcement. This is especially the case for matters impacted (e.g., IPR, PGR, advanced patent litigation, including FTC matters) by changes caused by the AIA and ANDA/ABLA regulatory schemas. Troy also advises upon and institutes multi-level front-end and back-end licensing programs coordinated with a client-focused business modeling approach, including acquisition, divestiture, and platform positioning. He strategically addresses multi-jurisdictional intellectual property integration issues, ranging from core and non-core patent portfolio due diligence analysis to global portfolio coordination matters (e.g., coordination of complex U.S. reexamination or reissue proceedings with European, Asian, and Australian appeals and opposition), among other services.

Troy regularly assists clients with respect to a broad range of technical disciplines involving the chemical, pharmaceutical, and biotechnological arts encompassing new drug (small-molecule, protein, recombinant, combinatorial technologies, assay, etc.) entities, assays, immunoassays, biological molecular technologies, API development and positioning, generic pharmaceuticals, biosimilars, pharmaceutical conjugates, surfactant technologies, agricultural compositions, food-based technologies, animal compositions, gellants, polyols, lubricants, coatings, elastomers, sealants, adhesives, biocides, medical devices, drug delivery formulations, laundry and cleaning products, inorganic and organic synthesis products, pharmaceutical supplements, personal care and cosmetic formulations, oil and gas technologies, alternative fuels, fuel cells, renewable energies, among others.

He also regularly counsels Fortune 100 mechanical and electrical companies with respect to intellectual property matters ranging from heavy-duty industrial products (e.g., diesel engines and aircraft technologies) to small appliances.

Prior to practicing patent law, Troy worked as a clinical consultant pharmacist, supervised drug research programs in coordination with the FDA, evaluated drug management protocols, and performed drug treatment trials on behalf of various hospitals and research institutions.